Envista Holdings NVST
NYSE NVST
$27.20 +0.27 (+1.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Envista Holdings (NVST) Other Accumulated Expenses (2018 - 2026)

Envista Holdings (NVST) posted quarterly Other Accumulated Expenses of $577.9 million for Q2 2026, up 3.42% year-over-year from $558.8 million in Q2 2025, and down 7.09% quarter-over-quarter from $622.0 million in Q4 2025.

Envista Holdings (NVST) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

Envista Holdings' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $577.9 million for Q2 2026.

  • In Q2 2026, Other Accumulated Expenses rose 3.42% year-over-year to $577.9 million; the TTM figure through Apr 2026 stood at $577.9 million (up 3.42% YoY), while the FY2025 annual figure was $622.0 million, up 12.36% from the prior year.
  • Other Accumulated Expenses for Q2 2026 stood at $577.9 million, down from $622.0 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $626.5 million in Q3 2025, with the low at $423.6 million in Q1 2023.
  • The 5-year median for Other Accumulated Expenses is $539.4 million (2022), against an average of $516.8 million.
  • The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses fell 21.76% in 2023, then gained 24.83% in 2024.
  • Envista Holdings' Other Accumulated Expenses stood at $471.4 million in 2022, then dropped by 3.33% to $455.7 million in 2023, then advanced by 21.48% to $553.6 million in 2024, then gained by 12.36% to $622.0 million in 2025, then slipped by 7.09% to $577.9 million in 2026.
  • Business Quant data shows NVST's Other Accumulated Expenses at $577.9 million in Q2 2026, $622.0 million in Q4 2025, and $626.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Envista Holdings 4.40 Bn 3.27 Bn 407.00 Mn

Historic Data

Download Data
DateValue
Jul 3, 2026 578.60 Mn
Apr 3, 2026 577.90 Mn
Dec 31, 2025 622.00 Mn
Sep 26, 2025 626.50 Mn
Jun 27, 2025 586.00 Mn
Mar 28, 2025 558.80 Mn
Dec 31, 2024 553.60 Mn
Sep 27, 2024 541.40 Mn
Jun 28, 2024 498.80 Mn
Mar 29, 2024 458.60 Mn
Dec 31, 2023 455.70 Mn
Sep 29, 2023 433.70 Mn
Jun 30, 2023 434.00 Mn
Mar 31, 2023 423.60 Mn
Dec 31, 2022 471.40 Mn
Sep 30, 2022 462.50 Mn
Jul 1, 2022 539.40 Mn
Apr 1, 2022 541.40 Mn
Dec 31, 2021 562.30 Mn
Oct 1, 2021 509.90 Mn